Kelvin SY Shi

Introduction Glaucoma is a progressive optic neuropathy characterized by the acquired loss of retinal ganglion cells and their axons, leading to characteristic optic nerve head changes and corresponding visual field loss.1,2 Among the various risk factors, intraocular pressure (IOP) remains the only proven modifiable factor for slowing disease progression.1,2 Reduction of IOP can be achieved with pharmacotherapy, laser interventions, or surgical procedures such as trabeculectomy.

Back to Journals » Clinical Ophthalmology » Volume 20 Original Research General Ophthalmology Authors Shi KS , Dorairaj EA , Wang M , Thé RY , Vasu P, Abubaker Y , Ang BCH, Dorairaj SK Received 11 March 2026 Accepted for publication 5 May 2026 Published 19 May 2026 Volume 2026:20 607636 DOI https://doi.org/10.2147/OPTH.S607636 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Sotiria Palioura Kelvin SY Shi,1 Emily...

Back to Journals » Clinical Ophthalmology » Volume 20 Review General Ophthalmology Authors Shi KS , Abubaker Y , Lang MV , Dönmez Gün R, Banoub RG, Ahuja AS , Wagner IV , Dorairaj SK Received 17 September 2025 Accepted for publication 9 February 2026 Published 20 February 2026 Volume 2026:20 Pages 1—11 DOI https://doi.org/10.2147/OPTH.S568183 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 6 Editor who approved publication: Dr Scott Fraser Kelvin SY...